Health Indian Pharmaceutical Company conducts Clinical Analysis for the Supplement to battle against Post COVID-19 difficulties June 21, 2021 ImmunoSEB + ProbioSEB CSC3 for post-resolution of mild to moderate COVID-19 patients Mumbai, Maharashtra
